Tocilizumab in the treatment of critical COVID-19 pneumonia: A retrospective cohort study of mechanically ventilated patients
Objectives: The purpose of this study is to evaluate clinical outcomes in patients with critical COVID-19 pneumonia requiring invasive mechanical ventilation who were treated with tocilizumab Design: Single-center retrospective cohort study Setting: Stony Brook University Hospital, a 600-bed academi...
Main Authors: | Matthew J. Fisher, Luis A. Marcos Raymundo, Melinda Monteforte, Erin M. Taub, Roderick Go |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220325443 |
Similar Items
-
Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
by: Tom van Kraaij, et al.
Published: (2020-04-01) -
Effects of Tocilizumab in COVID-19 patients: a cohort study
by: Christine A. Vu, et al.
Published: (2020-12-01) -
Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study
by: Tariq Kewan, et al.
Published: (2020-07-01) -
Effectiveness of Tocilizumab in a COVID-19 Patient with Cytokine Release Syndrome
by: Sadettin Uslu
Published: (2020-05-01) -
Subcutaneous tocilizumab treatment in patients with severe COVID-19–related cytokine release syndrome: An observational cohort study
by: Antonio Mastroianni, et al.
Published: (2020-07-01)